期刊簡介：
The Journal of Biomolecular Screening (JBS) is the leading peer-reviewed journal focusing on drug discovery sciences. JBS publishes information that enables researchers to evaluate current technologies and incorporate applications to enhance performance and objectives. Manuscripts and editorial commentary emphasize scientific and technical applications and advances in target identification/validation; lab automation and robotics; high-throughput screening (HTS); lead generation/optimization; virtual screening, chemoinformatics; diagnostic assays; assay development; assay technologies (novel applications, comparisons); data/image analysis, statistics and information technologies/methods; high content screening, imaging platforms; sample management (library design, compound logistics, chemical diversity); biological reagent production, characterization and management for drug discovery (cell lines, stem cells, surrogate tissues/species [xenopus, zebrafish, yeast]); genomic, proteomic screening; biomarkers; high throughput approaches to PK, ADME and predictive toxicology; legal, licensing issues.
期刊領域：
生物分子篩選雜志(JBS)是領先同行評審的期刊側重于藥物發(fā)現(xiàn)科學。 JBS發(fā)布信息，使研究人員能夠評估當前的技術和整合的應用程序，以提高性能和目標。手稿和社評強調(diào)科學和技術的應用和進步的目標識別/驗證，實驗室自動化和機器人技術，高通量篩選(HTS)，領先一代/優(yōu)化;虛擬篩選，化學信息學，診斷分析;檢測方法開發(fā)的檢測技術(小說應用比較)，數(shù)據(jù)/圖像分析，統(tǒng)計和信息技術/方法，高內(nèi)涵篩選，成像平臺，樣品管理(庫設計，化學多樣性，復合型物流)，生物試劑生產(chǎn)，鑒定和管理藥物發(fā)現(xiàn)(細胞株，干細胞，替代組織/物種[爪蟾，斑馬魚，酵母)，基因組學，蛋白質(zhì)組學篩選生物標志物，高通量的方法，PK，ADME和預測的毒理學法律許可問題。
鄭重聲明
①本頁面非期刊官網(wǎng),不以期刊名義對外征稿,僅展示期刊信息做參考.投稿、查稿,請移步至期刊官網(wǎng).
②如果您是期刊負責人且不想本平臺展示期刊信息,可聯(lián)系在線人員予以刪除.
③期刊VIP網(wǎng)優(yōu)先推薦您選擇 咨詢率高的SCI期刊。學術顧問可以為您提供發(fā)表支持服務，助您論文發(fā)表速度更快、通過率更高。
了解平臺的服務明白紙。
